Observational analysis demonstrates enhanced skin regeneration via macrophage reprogramming, suggesting new fibrotic treatment avenues.
The regulation of the immune system and promotion of myofibroblast heterogeneity in wounds are crucial for developing scar-reducing treatments. Currently no approved multifaceted drug exists that can fully inhibit fibrosis....
No takes yet. Share an insight, caveat, or question.
Xian et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: